Plasma ZAG has previously been shown to be negatively associated with insulin levels and HOMA-IR in humans with normal glucose tolerance, impaired glucose tolerance (IGT), and newly diagnosed type 2 diabetes mellitus (T2DM) [31]. This evidence concerns the gene AZGP1 and type 2 diabetes mellitus.